federal_register: E8-23830

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
E8-23830 Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Crystalline Free Acid Rule The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pharmacia & Upjohn Co., a Division of Pfizer, Inc. The supplemental NADA provides for veterinarian prescription use of ceftiofur crystalline free acid injectable suspension for the treatment of bovine foot rot (interdigital necrobacillosis). 2008-10-08 2008 10 https://www.federalregister.gov/documents/2008/10/08/E8-23830/implantation-or-injectable-dosage-form-new-animal-drugs-ceftiofur-crystalline-free-acid https://www.govinfo.gov/content/pkg/FR-2008-10-08/pdf/E8-23830.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pharmacia & Upjohn Co., a Division of Pfizer, Inc. The supplemental NADA provides for...

Links from other tables